Antagonist anti-CD40 monoclonal antibodies and methods for their use

Details for Australian Patent Application No. 2005323515 (hide)

International Classifications

Event Publications

16 November 2006 PCT application entered the National Phase

PCT publication WO2006/073443 Priority application(s): WO2006/073443

17 July 2008 Alteration of Name

The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc. 2006

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.